ArticleTranslational oncology2022

Authors' reply: Perspective: The approval and withdrawal of melphalan flufenamide (melflufen): Implications for the state of the FDA.

Fredrik H Schjesvold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.